MeiraGTx Holdings (MGTX) Net Cash Flow (QoQ) (2017 - 2025)
MeiraGTx Holdings (MGTX) Net Cash Flow (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
MeiraGTx Holdings |
910.47 Mn |
844.54 Mn |
74.89 Mn |
| Date | Value |
| Dec 31, 2025 |
492.32% |
| Sep 30, 2025 |
67.02% |
| Jun 30, 2025 |
-6.67% |
| Mar 31, 2025 |
-81.85% |
| Dec 31, 2024 |
-185.73% |
| Sep 30, 2024 |
223.14% |
| Jun 30, 2024 |
-79.76% |
| Mar 31, 2024 |
-116.58% |
| Dec 31, 2023 |
326.70% |
| Sep 30, 2023 |
-218.46% |
| Jun 30, 2023 |
150.73% |
| Mar 31, 2023 |
-63,921.62% |
| Dec 31, 2022 |
-99.82% |
| Sep 30, 2022 |
200.97% |
| Jun 30, 2022 |
-79.12% |
| Mar 31, 2022 |
-344.91% |
| Dec 31, 2021 |
81.93% |
| Sep 30, 2021 |
-9.10% |
| Jun 30, 2021 |
-175.90% |
| Mar 31, 2021 |
-132.54% |